Bloomberg.com: Worldwide

 Yep — for the past 4 years.  Wonder if it will ever happen?  Probably about the time I buy a Dexcom.

Abbott’s new Navigator device, for continuous blood-glucose monitoring, is approaching approval by the U.S. Food and Drug Administration.

Source: Bloomberg.com: Worldwide